Novel quinazolin–sulfonamid derivatives: synthesis, characterization, biological evaluation, and molecular docking studies

Nima Sepehri , Maryam Mohammadi-Khanaposhtani , Nafise Asemanipoor , Samanesadat Hosseini
Journal of Biomolecular Structure and Dynamics 40 ( 8) 3359 -3370

9
2022
Design, synthesis, in vitro and in silico biological assays of new quinazolinone-2-thio-metronidazole derivatives

Samira Ansari , Maryam Mohammadi-Khanaposhtani , Mohammad Sadegh Asgari , Ensieh Nasli Esfahani
Journal of Molecular Structure 1244 130889 -130889

9
2021
Synthesis, ADMT prediction, and in vitro and in silico α-glucosidase inhibition evaluations of new quinoline–quinazolinone–thioacetamides

Sajedeh Safapoor , Mohammad Halimi , Minoo Khalili Ghomi , Milad Noori
RSC advances 13 ( 28) 19243 -19256

6
2023
Design, synthesis, in vitro, and in silico biological evaluations of coumarin-indole hybrids as new anti-α-glucosidase agents

Davood Rezapour Niri , Mohammad Hosein Sayahi , Somayeh Behrouz , Ali Moazzam
BMC chemistry 16 ( 1) 84 -84

6
2022
Novel aryl (4-phenylpiperazin-1-yl) methanethione derivatives as new anti-Alzheimer agents: Design, synthesis, in vitro and in silico assays

Samira Ansari , Milad Noori , Keyvan Pedrood , Maryam Mohammadi-Khanaposhtani
Journal of Molecular Structure 1262 132945 -132945

6
2022
Design, synthesis, and biological evaluation of new indole-acrylamide-1, 2, 3-triazole derivatives as potential α-glucosidase inhibitors

Seyed Esmaeil Sadat-Ebrahimi , Hiva Babania , Maryam Mohammadi-Khanaposhtani , Mohammad Sadegh Asgari
Polycyclic Aromatic Compounds 42 ( 6) 3157 -3165

6
2022
Synthesis, molecular dynamic, and in silico study of new ethyl 4-arylpyrimido [1, 2-b] indazole-2-carboxylate: Potential inhibitors of α-glucosidase

Mojtaba Gashghaee , Homa Azizian , Mehdi Adib , Maryam Mohammadi-Khanaposhtani
Journal of Molecular Structure 1257 132507 -132507

5
2022
4
2023
Design, synthesis, in vitro, and in silico evaluations of benzo [d] imidazole-amide-1, 2, 3-triazole-N-arylacetamide hybrids as new antidiabetic agents targeting α-glucosidase

Faeze Yousefnejad , Mahyar Mohammadi-Moghadam-Goozali , Mohammad Hosein Sayahi , Mohammad Halimi
Scientific Reports 13 ( 1) 12397 -12397

4
2023
Design, Synthesis and In vitro Cytotoxicity of New 1, 2, 3-triazol-and Nitrostyrene Hybrids as Potent Anticancer Agents

Zahra Tashrifi , Maryam Mohammadi-Khanaposhtani , Mehdi Shafiee Ardestani , Maliheh Safavi
Letters in Drug Design & Discovery 16 ( 2) 213 -219

2
2019
2024
In vivo and in silico evaluations of a synthetic pyrano [3, 2-c] quinoline derivative as a potent anti-diabetic agent

Nafiseh Zare , Fatemeh Bandarian , Ensieh Nasli Esfahani , Bagher Larijani
Journal of Diabetes & Metabolic Disorders 1 -7

2023
2022
Novel fused 1, 2, 3-triazolo-benzodiazepine derivatives as potent anticonvulsant agents: design, synthesis, in vivo, and in silico evaluations

Arefeh Shafie , Maryam Mohammadi-Khanaposhtani , Mehdi Asadi , Nastaran Rahimi
Molecular diversity 1 -11

31
2019
Diphenyl-substituted triazine derivatives: synthesis, α-glucosidase inhibitory activity, kinetics and in silico studies

Shahbaz Shamim , Khalid Mohammed Khan , Muhammad Ali , Mohammad Mahdavi
Future Medicinal Chemistry 15 ( 18) 1651 -1668

3
2023
2018